OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

EVOTEC SE INH O.N./  DE0005664809  /

TradeGate
1/23/2025  10:40:46 AM Chg. -0.045 Volume Bid10:41:42 AM Ask10:41:42 AM Market Capitalization Dividend Y. P/E Ratio
7.900EUR -0.57% 14,177
Turnover: 112,647.560		 7.900Bid Size: 1,100 7.905Ask Size: 1,100 1.4 bill.EUR - -
GlobeNewswire 5/14/2024 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 12/11/2023 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire 11/7/2023 Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire 8/20/2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
GlobeNewswire 2/7/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 2/7/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis
GlobeNewswire 2/15/2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire 1/8/2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire 9/14/2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire 11/29/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 11/10/2011 Evotec reports nine months results: Upside materialising
GlobeNewswire 11/3/2011 Evotec to Report Third Quarter Results on 10 November 2011
GlobeNewswire 10/27/2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire 10/20/2011 Evotec and APEIRON Biologics start next project on the Cbl-b target
GlobeNewswire 10/5/2011 Evotec announces second multi-target collaboration with UCB
GlobeNewswire 9/29/2011 Evotec acquires remaining 30% of Indian Joint Venture from DIL
GlobeNewswire 9/9/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire 9/5/2011 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire 9/5/2011 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire 8/18/2011 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire 8/11/2011 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire 8/11/2011 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire 8/4/2011 Evotec to Report Second Quarter 2011 Results on 11 August 2011
GlobeNewswire 7/7/2011 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases
GlobeNewswire 6/30/2011 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...